BGIM
ELV icon

Boussard & Gavaudan Investment Management’s Elevance Health ELV Stock Holding History

Boussard & Gavaudan Investment Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-2,267
Closed -$274K – 69
2014
Q3 		$274K Buy
+2,267
New +$260K 0.16% 24

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Boussard & Gavaudan Investment Management's ELV Position: Q4 2014 in Review

Boussard & Gavaudan Investment Management sold out of Elevance Health (ELV) in Q4 2014, closing a stake of 2,267 shares — an estimated $274K sold.

Boussard & Gavaudan Investment Management first reported a position in ELV in Q3 2014 and held it in 1 quarter. The position peaked at $274K in Q3 2014. 720 funds tracked by Wall St. Rank hold ELV as of Q4 2014.

  • Boussard & Gavaudan Investment Management reported no remaining Elevance Health position as of Q4 2014 after selling out during the quarter.
  • Boussard & Gavaudan Investment Management sold 2,267 Elevance Health shares in Q4 2014, an estimated $274K.
  • Boussard & Gavaudan Investment Management first reported a position in Elevance Health in Q3 2014 and held it in 1 quarter.
  • Boussard & Gavaudan Investment Management's Elevance Health position peaked at $274K in Q3 2014.
  • 720 funds tracked by Wall St. Rank held Elevance Health as of Q4 2014.

Based on Boussard & Gavaudan Investment Management's 13F filing for Q4 2014, filed 10 Feb 2015.